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AbstrACt
background A high level of photoprotection is required 
by people with xeroderma pigmentosum (XP), a rare skin 
disease, to reduce skin cancer and other risks. However 
poor photoprotection is thought to be widespread.
Purpose This study examines the influences on 
photoprotection behaviours in adults with XP.
Design Inductive qualitative study with semistructured 
interviews. Analysis employed a framework approach.
setting National sample recruited through a specialist XP 
centre in London.
Methods Semistructured interviews at patients’ homes. 
All transcripts were coded and themes charted for 
each participant. Comparisons within and across cases 
identified common themes and differing motivations 
and approaches to photoprotection. Credibility of 
interpretations assessed through patient/carer input and 
clinic adherence scores.
Participants 25 adults (17 male, eight female) aged 16–
63 years with diagnosed XP attending a specialist centre. 
18 lived outside London.
results Awareness of risks of ultraviolet radiation (UVR) 
and photoprotection was high. However, photoprotection 
behaviours varied according to perceived necessity and 
concerns. Three behavioural responses were identified: 
(1) ‘dominated’ by planning and routines to achieve a 
high level of photoprotection with significant activity 
restrictions and psychosocial impacts. (2) ‘resistant’ to 
photoprotection with priority given to avoiding an illness 
identity and enjoying a normal life. (3) Photoprotection’ 
integrated’ with an individual’s life with little psychosocial 
impact. These responses were influenced by illness, 
personal and contextual factors including age, life stage 
and social support. Only the ‘integrated’ group achieved an 
equilibrium between perceived ‘necessity’ and ‘concerns’.
Conclusions The personal balance between perceived 
risks of UVR and social/psychological ‘concerns’ led to 
differing behavioural responses and contributes to an 
understanding of adaptation and normalisation in chronic 
illness. The study will also inform a series of individualised 
behavioural interventions to reduce measured UVR 
exposure among people with XP that are potentially 
applicable to other conditions with high risks of skin 
cancer.
IntroDuCtIon
Globally the prevalence of chronic disease is 
increasing but adherence to recommended 
therapies remains persistently low; on average 
50% of all patients with long-term therapy for 
chronic disease in developed countries are 
non-adherent to medication1 and 50%–80% 
to behavioural changes.2 Both forms of 
non-adherence increase risks of morbidity 
and mortality with implications for demands 
on health services and costs of care.3 
Research conducted to explain high levels of 
non-adherence with medical advice has iden-
tified a range of illness-related, psychosocial 
and social structural influences.4 5 However, 
very few studies have examined the deter-
minants of non-adherence among people 
with a rare disease, defined by the European 
Union as conditions that affect fewer than 5 
strengths and limitations of the study
 ► Qualitative home-based semistructured interviews 
elicited detailed accounts of individuals’ perceptions 
and photoprotection behaviour.
 ► The analysis went beyond identification of individual 
themes to identify three multidimensional categories 
of response to photoprotection, with their credibility 
enhanced through discussion with the patient/carer 
(patient and public involvement) group and data on 
prior specialist nurse ratings of adherence.
 ► The research was conducted with patients in the 
National Health Service who attended a national 
specialist centre for xeroderma pigmentosum (XP) 
which may have influenced their knowledge and 
attitudes to XP.
 ► It was not feasible to conduct follow-up interviews 
to examine the influences on transitions between 
different modes of response given the significant 
demands of the overall research programme on a 
small sample of people with this rare disease.
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in 10 000 people in the general population.6 Rare diseases 
in totality are however not so rare, with over 6000 rare 
diseases identified. It is also estimated that 7% of the 
population will be affected by a rare disease at some point 
in their lives.6
This study focuses on adherence to recommended life-
style changes among patients with xeroderma pigmen-
tosum (XP), a rare disease caused by mutations in any of 
eight genes, resulting in defective repair of ultraviolet radi-
ation (UVR) induced DNA damage.7 The incidence is 2.3 
per million live births in Western Europe.8 Patients may 
develop skin cancers from childhood, with an estimated 
2000-fold and 10 000-fold increased risk of melanoma and 
non-melanoma skin cancers, respectively, together with 
increased risks of ocular problems and neurodegenera-
tion.9 About half the patients were ‘burners’ who suffer 
abnormal and severe sunburn reactions and blistering as 
measured by an XP sunburn score and are at the highest 
risk of neurological degeneration. ‘Non-burners’ have an 
entirely normal sunburn response but have the highest 
risks of pigmentation changes, skin cancers at an early 
age and ocular problems.10
There is currently no curative treatment for XP. 
Improving life expectancy and reducing risks of skin 
cancers and eye disease therefore depends on rigorous 
long-term UVR protection. This involves regular use of 
sunscreen (Sun protection factor (SPF) 50+), covering 
arms and legs with layers of clothing and wearing gloves, 
a UVR protective visor or other head/face covering, UVR 
protective glasses and attaching UVR protective film to 
windows.11
Research to date has shown that sun protective knowl-
edge is high among general populations12 and among 
high-risk groups13 14 but has not adequately explained low 
adherence. Furthermore, no research has focused specif-
ically on people with XP, although expert clinical opinion 
suggests these patients may vary widely in the degree to 
which they photoprotect (H Fassihi, personal communi-
cation 2016).
The current study forms one component of a 5-year 
National Institute for Health Research (NIHR) funded 
programme of research that aims to develop and evaluate 
interventions to increase adherence to photoprotection 
and thus reduce measured UVR exposure among people 
with XP.15 The programme is underpinned by a systematic 
theoretically based framework to guide behaviour change 
interventions.16 The first mixed-methods phase there-
fore aimed to achieve a comprehensive understanding 
of photoprotection behaviour to inform the develop-
ment of individualised photoprotection interventions.15 
The quantitative studies comprised a cross-sectional 
survey to assess potential clinical, sociodemographic and 
behavioural correlates of photoprotection behaviour 
and a number of one (N-of-1) study using daily diaries to 
record photoprotection activities and ratings of potential 
psychosocial predictors. These were complemented by 
this more in-depth qualitative study to explain photopro-
tection behaviour.
AIMs
To elicit individuals’ personal accounts of their photopro-
tection behaviour and identify the range of factors that 
influence their behaviour.
MethoDs
Design
Inductive qualitative study based on semistructured 
interviews that were analysed following a framework 
approach.17 The Standards for the Reporting of Qualita-
tive Research guidelines were followed.18
Patient and public involvement
Six members of the patient and public involvement (PPI) 
group were recruited. However, two parents dropped out 
as their child was having severe health problems. The 
remaining four PPI members (one patient, two parents, 
one teacher) participated in two discussion sessions to 
consider the qualitative findings. One parent was a co-in-
vestigator and as part of the research team attended 
meetings throughout the research from the initial devel-
opment of the application.
All study participants were sent a brief newsletter that 
provided study feedback. They were also invited to a 
thank you event that included informal discussion of the 
results. Further dissemination will occur following the 
trial phase of the research.
recruitment
The study sample was recruited from the national 
specialist XP service in London that is part of the National 
Health Service with universal access based on medical 
need. Eligible adults were identified from the register of 
clinic attenders and satisfied the following criteria: aged 
16 years and over, confirmed diagnosis of XP (reduced 
unscheduled DNA repair in fibroblast DNA repair assay), 
no neurodegeneration, adequate English to participate 
in an interview and had not opted out of research.
A research nurse, who was employed by the research 
programme and had no clinical contact with patients, 
organised study recruitment. She sent study information 
to the 38 eligible patients and 2 weeks later followed up 
with a phone call to enquire whether they were inter-
ested in participating. Seven could not be contacted and 
six declined due to time or not wishing to talk about XP. 
These six patients comprised three men and three women 
with a spread of ages. Their clinic notes also identified 
varying photoprotection behaviours thus identifying their 
similarity to the interviewed sample.
Data collection
Twenty-five one-to-one interviews were conducted. 
They were held in a private room in the patient’s home 
with the exception of one phone interview for logis-
tical reasons. Interviews were carried out between early 
February and June 2016 by a research fellow (JWal) and 
research assistant (RA) who are both trained in health 
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psychology and are experienced interviewers but had not 
previously studied XP. Participants were aware that they 
were non-clinical researchers employed at King’s College 
London to conduct the research. An interviewer (female) 
visited the patient’s home with the research nurse who 
had made the initial contact with participants to provide 
continuity. She introduced the interviewer and obtained 
informed consent but was not present for the interview 
and when required looked after participants’ children.
Interviews took the form of a guided conversation struc-
tured by a topic guide (online supplementary table 1). 
They began with a brief reminder of the aims of the study 
and then focused on aspects of the patients’ personal story 
to identify individuals’ early experience of XP. This was 
followed by eliciting their current views and experiences 
of photoprotection, the psychosocial impacts of photo-
protection and support by family and friends. Topics 
were discussed in any order according to the flow of the 
conversation and responses probed and clarified as neces-
sary. Interviews were audio-recorded with permission and 
mainly took 30–60 min. Participants were generally willing 
to provide detailed accounts of their photoprotection 
behaviour. This is likely to have been facilitated by the 
home environment and their positive views of both the 
clinic and the aims of the research. However reflective 
notes made following the interview identified a few partic-
ipants becoming upset in thinking about XP. Some also 
preferred not to discuss earlier stages and only to focus 
on the present. However, they were all happy to continue 
the interview.
Data saturation was achieved with the 25 interviews 
with no new beliefs or explanations identified in the final 
interviews.
Analysis
This occurred alongside data collection and was based 
on a framework approach.17 This goes beyond a thematic 
analysis and involves methods that are geared towards 
producing practice-oriented findings and was therefore 
appropriate for a study aiming to inform behavioural 
change interventions.19
Tapes were transcribed verbatim, checked for accuracy 
and corrected transcripts entered into QSR NVivo V.11 
which is a qualitative data analysis package designed 
for working with text or multimedia information where 
in-depth analysis is required (https://www. qsrinter-
national. com/ nvivo/ what- is- nvivo). Transcripts and 
field notes were initially read to identify key themes. 
Coding was then undertaken with the initial coding 
framework adapted as new items arose. One author 
(RA) had a major role in coding (ie,’ indexing’) with 
two other authors (JWal, MM) repeating and reviewing 
the coding which was discussed to achieve consensus. 
Analysis involved comparisons within and across cases 
assisted by ‘charting’ which involves summarising data 
by thematic content for each case to identify relation-
ships between codes.19 These charts were further exam-
ined through a process of ‘mapping and interpretation’ 
leading to emerging ideas and relationships. Preliminary 
behavioural categories were tested through further anal-
ysis of transcripts to identify the fit for all cases with modi-
fications introduced as required. This iterative process 
finally led to a threefold categorisation based on percep-
tions of risks of UVR and the psychosocial impacts of 
photoprotection.
Credibility and triangulation
The credibility of emergent categories in terms of their 
congruence with reality forms a key aspect of validity 
in qualitative research.20 In this case credibility was 
informed by the PPI group who participated in two 
sessions to discuss the qualitative findings and in two 
clinical discussion groups held with a total of 11 clinical 
specialists who undertake the patients’ annual check to 
identify the congruence of our identified patient catego-
ries with their clinical experience. The level of adherence 
with photoprotection of our three patient categories was 
also examined based on prior clinic reviews by specialist 
nurses using a 13-item measure.21
results
Characteristics of participants
Twenty-five adults were interviewed. Participants were 
aged 16–63 years and 18 lived outside London. Seven-
teen were male and 8 female reflecting the adult clinic 
case load (26 male and 17 female). Eight were European 
(mainly white British), eight of Pakistani ethnicity and 
seven mainly of Middle Eastern, Indian or Bangladeshi 
background, reflecting the relatively high prevalence of 
XP in Pakistan and the Middle East.7
Fifteen participants were defined as ‘non-burners’ 
(ie, normal sunburn response) and 10 as ‘burners’ (ie, 
abnormal sunburn response to minimal sun exposure).10 
Those categorised as ‘burners’ had all begun some form 
of photoprotection in childhood following recognition 
that they burned easily, whereas half the ‘non-burners’ 
had begun photoprotection after 10 years of age. Self-re-
ported clinical diagnosis occurred more than 5 years ago 
for all but five participants and all currently attended the 
specialist clinic annually. The ‘burners’ had experienced 
reddening and blistering, pigmentation changes, partic-
ularly freckles and benign lesions. The ‘non-burners’ 
had often experienced some pigmentation changes 
and nearly all had experienced removal of one or more 
cancerous lesions.
Knowledge of risks and photoprotection
Participants were all aware that XP is a long-term condi-
tion with risks of skin damage and lesions. They were also 
aware of requirements for photoprotection and explained 
that their knowledge had increased over time through 
greater experience of the condition and attending the 
specialist clinic. For example, some participants initially 
thought only the face is affected by UV exposure and 
were therefore surprised to require lesions removed from 
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their neck, arms or legs. As participant 28 (female, aged 
28 years) explained, ‘.so my neck, so then I’ll wear a hat and 
I’ll wear sun cream more often, and I’ll wear my sunglasses. 
Then there’s bits on your arms, so I’ll start wearing long sleeve 
t-shirts. And then this happened on my  leg. but now I’m like no, 
I’m going to buy leggings and I’m going to wear leggings with 
long sleeve tops.’
All participants engaged in some photoprotection 
but, when asked why they did not undertake particular 
aspects, often found this difficult to answer. However, 
further discussion identified a range of positive and nega-
tive factors that influenced how they interpreted and 
balanced medical and psychosocial priorities. This led to 
identifying three main types of response to photoprotec-
tion: ‘dominated’ by photoprotection, ‘resistant’ to photo-
protection and ‘integrated’ photoprotection (box 1). 
See online  supplementary table 2 for participants’ age/
sex and behavioural response category.
responses to photoprotection
Dominated by demands of photoprotection
This group comprised four men (one ‘burner’ and three 
‘non-burners’) aged between 21 years and 28 years who all 
described a very high level of photoprotection. Their major 
motivation for undertaking rigorous photoprotection was 
their perception of the harmful effects of UVR. The three 
non-burners feared cancerous lesions and worried about 
a reduced length of life, whereas the major worry for the 
one ‘burner’ (participant 15 aged 22 years) was having 
very painful and unpleasant sunburn reactions. However, 
for all participants an immediate concern was the effects 
of UVR on their appearance due to freckling and other 
pigmentation changes including facial scars following 
surgery. For example, participant 14, a non-burner (male, 
aged 21 years), explained, ‘If you take it purely objectively, I 
don’t think I’m as unfortunate as some skin patients are (effects 
on appearance). But you still worry about it. Yeah, that’s a main 
worry.’
People ‘dominated’ by photoprotection had begun sun 
protection in childhood but described adjusting better 
to it as they got older and often did not want to think 
back to earlier stages, describing this as ‘too long ago’. 
However, participant 7 (male, aged 27 years) explained 
that at school and college he never used his sunscreen 
‘because I wanted to feel normal, that’s why. I didn’t want any 
questions, or any remarks from friends or people that I didn’t 
know, and I did not want to look abnormal to anyone else.’ This 
changed when he had his first surgery to remove a basal 
cell carcinoma which he described as a ‘reality check’ and 
‘wake-up call’ as ‘I was putting myself in harms’ way for no 
reason…just destroying my own skin.’ From that time he gave 
considerable emphasis to the risks of UVR and the need 
for rigorous photoprotection.
All four respondents described having UVR protective 
film on the windows of their home and car and used a 
UVR meter to assess risks and identify appropriate envi-
ronments and locations. They also described well-estab-
lished behavioural routines for photoprotection. This 
involved applying sunscreen whatever the season and 
wearing two or three layers of protective clothing, gloves 
and a hat or cap with a hoodie or a visor when outside 
during the day. A visor provides full cover of the face and 
head and is usually only worn by children but was worn by 
three people categorised as ‘dominated’. They described 
a visor as uncomfortable to wear, bulky to carry around, 
and attracting stares and comments. However, users 
regarded this as necessary to achieve sufficient protection 
and regarded wearing a visor as part of ‘going out properly 
protected’. The one participant in the ‘dominated’ group 
who did not wear a visor but otherwise engaged in rigorous 
photoprotection described a visor as ‘suffocating’ and as 
having negative psychosocial impacts, ‘.totally make me feel 
abnormal. Just wearing a hat, cap and glasses all the time, I’ve 
gotten people questioning like mad, so imagine wearing a visor.’ 
(participant 7, male, 27 years)
Participants ‘dominated’ by photoprotection 
explained how their practices had shifted from a delib-
erative action into a routine or ‘habit’ which they now 
‘do without thinking, it becomes part of your daily routine’. As 
one participant observed, ‘I think I’m motivated by keeping 
myself safe and I don’t want to develop any skin cancers, which 
is a problem for my condition. But really, rather than motivation 
it’s something I do just because it’s a deeply ingrained in me 
box 1 behavioural responses to photoprotection among 
people with xeroderma pigmentosum (XP)
Dominated by demands of photoprotection
The major driver for rigorous photoprotection was a high fear of ul-
traviolet radiation (UVR)-related risks. Although concerned about the 
impacts of photoprotection on activities and experiencing emotional 
distress, these did not lead to reduced photoprotection.
resistant to photoprotection
The major driver was the desire to live a normal life which conflicted 
with rigorous photoprotection.
For a group of predominately younger adults their desire to distance 
themselves from a stigmatised identity and be accepted as normal by 
their peer group outweighed concerns about the clinical risks of UVR. 
This led to ‘strong resistance’ in terms of concealing their condition by 
undertaking fairly limited photoprotection and often not disclosing their 
condition to others.
For a group of mainly older adults the requirements for photoprotection 
had no significant impact on self-identity or disclosure but they ques-
tioned the personal risks of UVR, its perceived efficacy and the priority 
given to other things in life. This led to ‘occasional resistance’ with gaps 
in their photoprotection, especially going out for short periods without 
sunscreen.
Integrated photoprotection
UVR protection was  integrated into normal life and not perceived as 
disruptive to activities or an emotional burden. Some achieved this by 
largely staying indoors which they were used to from childhood and 
was their preferred life style. Others lived a more usual life and were 
assisted in this by the cooperation of friends/family and among older 
people by the changing values, lifestyles and expectations of older age. 
Many participants, although confident in their photoprotection, also ac-
knowledged scope for improving their routines.
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and because I’ve been doing it forever.’ (participant 13, male, 
aged 28 years)
This high level of photoprotection carried considerable 
personal costs. These included restrictions on choice of 
job with risks of exposure to UVR forming an important 
consideration. As one participant (no.14, male, aged 21 
years) explained, ‘It’s affected the kind of jobs that I can look 
for. I only choose something that’s inside in a safe environment 
and I really can’t go for anything else.’ He now works as a 
shop assistant in a large supermarket. Other participants 
were also employed in safe environments, as a barber, in 
the family takeaway and as a health scientist, rather than 
doing their job of choice.
Participants also described missing out on social events 
because they did not want to wear UVR protection or 
did not regard it safe to go outside even with full protec-
tion. For example, participant 13 (male, aged 28 years) 
explained, ‘I make excuses about not going out with friends 
and prefer to be indoors between 11 and 4 when the sun is at its 
highest.’
If going out during the daytime was unavoidable they 
undertook considerable preparation. As participant 22 
(male, aged 26 years) explained, ‘the only times I go out 
during the day is if I’m going from a car to a building or building 
to car, or if it’s completely unavoidable….’
This decision in turn cues his usual routine that involves 
‘suncream, visor, everything’. He described this as taking 
him ‘……about half an hour just to get ready because I’ve got 
to apply my sun cream, then I’ve got to be sure I haven’t missed 
any areas. I also apply lip balm which is UV protected. Then once 
I’ve applied my sunscreen I apply my camouflage (to hide scars). 
I apply two camouflages.’ He also explained, ‘If I’ve got to be 
somewhere for 5pm I’ll have to leave at 4.30pm which means I’ve 
got to cover up between (workplace) and the tube station. So, I 
need the visor that day.’
This group referred to the psychological costs of a 
high level of photoprotection in terms of being viewed 
as different or not ‘normal’. They described no longer 
being upset by stares and questions about their clothing 
and if people continued to ask questions or make 
comments, they now felt more confident and able to 
‘put them in their place.’ However, they still sometimes 
avoided situations that might lead to ‘snide remarks’, such 
as taking a taxi rather than a bus when school children 
were travelling.
Despite considerable support from family and friends, 
this group described feeling emotionally distressed 
about the demands of photoprotection and restrictions 
on their activities. For two participants the impacts were 
quite severe, for example, participant 7 (male, aged 
27 years) explained, ‘whatever I do XP is on my mind first’ 
and described XP as ‘affecting me emotionally quite a bit as 
well.,It’s just you get obsessed and get that depressing feeling. You 
can’t do much in life.’
Similarly, participant 22 (male, aged 26 years) described 
‘feeling down’ about having XP and its effects on his life and 
got ‘bouts of depression’ about three or four times a year. 
However, these various adverse effects did not disrupt 
their high level of photoprotection given their fears of 
the potential clinical risks.
Resistant to photoprotection
This group comprised 11 participants, aged 20–55 years, 
with 5 ‘burners’ and 6 ‘non-burners’. All accepted their 
diagnosis of XP and were aware of the risks of UVR and 
photoprotection practices. They therefore had the capa-
bility to photoprotect but acknowledged a lack of motiva-
tion with other priorities.
We identified five people (two men and three women, 
aged 21–37 years) as ‘strong resistors’ as they described 
very limited photoprotection that largely reflected their 
desire to distance themselves from XP and be accepted 
as normal by others. For example, participant 24 (female, 
aged 28 years) had experienced several surgeries to 
remove skin cancers and benign lesions and was partic-
ularly concerned about surgery to her face. Neverthe-
less, she described ‘strong resistance’ to photoprotection 
and often joined her friends for activities in the sun, 
did not consistently reapply sunscreen and sometimes 
went out wearing shorts or summer tops, because as she 
explained, ‘I just want to be seen like everybody else’ and ‘I 
think you can just let these things (photoprotection) become you 
and I don’t want to be about XP. XP is a tiny part of me.’ She 
therefore sometimes thinks, ‘…do you know what, I’m just 
going to get on with my life.’
She excused her behaviour at the interview by saying 
that when she was out she ‘shade hopped’ and also gained 
reassurance from knowing that the clinic would identify 
and manage any problems.
Concerns about feeling different and viewed by others 
as possessing an unacceptable difference was common 
in this group although their particular circumstances 
differed. For example, an Asian participant (partici-
pant 6, male, aged 20 years) described freckles as highly 
unusual and abnormal on a person with Asian skin and 
reported that comments and questions by the Asian 
community made him feel ‘like an outsider’ which corre-
sponds with the notion of ‘felt stigma’ or feelings of 
shame associated with an unacceptable difference.22 This 
response contributed to his stress and loneliness and to 
a reluctance to increase the obviousness of his condition 
through rigorous photoprotection.
This subgroup of ‘strong resistors’ therefore described 
tensions between their desire to be seen and participate 
as normal, and worries about the effects of UVR without 
sufficient protection. For example, participant 18 (female, 
aged 27 years) worries about cancer but often feels ‘a bit 
left out’ as she can’t go outside at lunch with colleagues. 
She also acknowledged that although she sometimes 
wears long sleeves in summer, she does not usually wear 
a hat or reapply sunscreen which she regarded as greasy 
and staining. She explained that ‘some days I don’t bother 
with cream or covering up…Sometimes I think screw it, just go 
out. Then I think, oh, sugar,….But there’s consequences, just like 
oh my god.’ Similarly participant 12 (male, aged 26 years) 
explained that he worries about life expectancy and 
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appreciates the advice and support given by the clinic but 
still goes out and socialises in the summer ‘…just to make 
myself feel better really, That’s about it.’.
Concerns about being perceived and responded to in 
terms of XP led to concealing the condition by reduced 
photoprotection, the use of a tinted foundation with a 
lower SPF and reluctance to disclose their condition to 
others. Reminders to photoprotect by family members 
were also often described as unhelpful as participant 12 
(male, aged 21 years) explained, ‘I just think it’s a constant 
reminder that I’m different. So that’s why I don’t really like them 
(reminders).’.
The other six people formed a subgroup of ‘occa-
sional resistors’. They were all men and mainly in their 
mid-30s to mid-50s. They were not bothered about people 
knowing about their XP but had gaps in their photopro-
tection routines, often going outside for short periods 
without sunscreen. This appeared to partly reflect percep-
tions of low personal risk if they had lived 20 years or 30 
years without major problems. There was also a view that 
life is uncertain and that exposure to UVR is just one of 
many risks they might encounter and so not a priority. 
They therefore preferred to ‘live for today’ and have 
‘a happy life despite XP’. As participant 20 (male, aged 
55 years) explained, ‘I don’t automatically put on sunscreen 
everyday even though I know I must….there’s no downsides to 
sunscreen, so it’s just time or not thinking about it or being too 
busy, or thinking no I can’t be bothered.’ He later explained, ‘I 
would rather do things that give me pleasure in life rather than 
get overly anxious about the ransom to the possible outcomes of 
not taking enough care.’
Some people referred to specific personal experiences 
as shaping these views, such as a close relative dying unex-
pectedly at a young age. Other reasons given for resisting 
rigorous photoprotection was their questioning the effec-
tiveness of sunscreen or of photoprotection, generally, 
especially if they had experienced lesions on parts of the 
body normally covered.
All participants in the ‘resistant’ category thus empha-
sised the importance of leading a normal life but differed 
in whether the major influence on their behaviours arose 
from feelings of unacceptable differentness, or from 
perceptions of personal UVR risk being outweighed by 
other life priorities and risks.
Integrated photoprotection
This category comprised five men and five women who 
represented the full age range from 16 years to 63 years, 
with four ‘burners’ and six ‘non-burners’. All currently 
accepted the need to undertake photoprotection, 
although a few people described struggling initially as the 
demands of photoprotection made them feel like a ‘sick’ 
person. However, over time these practices had become 
‘automatic’, ‘habitual’ and ‘just second nature’. Photoprotec-
tion was therefore not currently viewed as a major prac-
tical or emotional burden leading to a ‘non-normal’ life 
and illness identity but described as ‘just a part of life … 
It’s just habit now, a routine, what I do….It’s just second nature 
I think for me’ (participant 19, male, aged 18 years). Simi-
larly photoprotection was referred to as ‘.no hardship to 
do because I just do it as part of my daily routine’ (participant 
16, female, aged 63 years). These participants generally 
felt comfortable and confident in their photoprotection 
routines and currently did not worry much about the 
risks of UVR.
This accommodation to photoprotection was described 
as occurring in one of two ways. A group of younger 
people diagnosed in childhood had adapted by spending 
most of their time indoors and now preferred this. For 
example, participant 19 (male, 18 years) was diagnosed 
when 9 years old but began to protect much earlier. 
Currently his routine was to set off for work at 6:00 when 
dark and his father collected him later by car. Otherwise 
he was mainly in the house and preferred being indoors 
where he played with the computer. Participant 1 (female, 
aged 45 years) also described her need to keep out of the 
sun as fitting quite well with her life because she was at 
home most of the day looking after children.
Others emphasised how they accommodated the 
requirements of photoprotection without withdrawing 
indoors. For younger people this was often facilitated by 
friends or family members who accepted their need to 
avoid UVR and adjusted activities to ensure that they were 
not made to feel different or excluded.
‘….especially when we’re going out and there’s a place that’s 
not safe and then they all understand we probably need to move 
somewhere else and not do what everyone wants to do, which is 
to enjoy the sunlight.’ (participant 9, male, aged 38 years)
Family members often organised activities when the sun 
was low, encouraged indoor sports and going on holiday 
in the UK rather than to hotter countries. Similarly, part-
ners might adapt their roles, as participant 10 (male, aged 
39 years) explained,
‘I’m the one who would normally be staying in the car (with 
window  film). and the missus would actually go into the shops, 
into the street to find whatever we need to get.’, ‘My wife tends 
to do the outdoor activities with the kids, and I do the indoors.’
For older people their accommodation of photopro-
tection had often become easier through their long-
standing experience of XP. As participant 16 (female, 
aged 63 years) commented, ‘Because I’m this great age now, 
I’m used to it….it’s just part of my daily routine now….the only 
time it impacts is if I’m invited to an outdoor event and either I 
don’t go or wear a hat and stick to the shade….but that’s the only 
time it impacts you. But I’m used to it now’ (laughter).
For older people, the personal social costs of photopro-
tection were also often facilitated by changes in what they 
expected and wished to do, as participant 21 (male, aged 
62 years) explained, ‘When younger I wanted to sunbathe and 
go on holidays with friends to hot countries but as the years went 
by I got used to it. Now it doesn’t bother me.’
Older people who had integrated photoprotection 
in their lives also described rejecting any stigma asso-
ciated with photoprotection, with any negative views 
and comments described as ‘other people’s problem, not my 
problem’.
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People who had integrated photoprotection into their 
lives described feeling confident that their routines 
provided adequate personal protection. However they 
sometimes acknowledged scope for improvement, 
including the need to apply sunscreen more regularly 
and give more emphasis to UVR protection on cloudy 
days. They may also have occasionally not been aware 
that their photoprotection practices were not sufficiently 
rigorous as these had become well established habits they 
no longer thought about.
Credibility and triangulation
Findings of different responses to photoprotection advice 
were presented and discussed with the four active members 
of the PPI  team. They endorsed the findings with a minor 
revision regarding a subgroup that was adopted.
The two discussion groups with clinical specialists indi-
cated that they regarded the three emergent categories 
as fitting with their clinical experience. They also viewed 
the data as helpful in increasing their understanding of 
the range of psychosocial meanings and contextual influ-
ences on photoprotection behaviour.
Patient data for a 13-item measure of photoprotection 
that is routinely used by clinic nurses to assess adherence 
with photoprotection21 was examined following comple-
tion of data analysis so as not to influence how we inter-
preted the interviews and categorised participants. This 
recorded very high photoprotection behaviour scores for 
the ‘dominated’ group, whereas the ‘resistors’ had the 
lowest mean score with all scoring 7 or less apart from one 
participant (participant 8, male, 55 years) whose score 
was higher as a result of having dermagard on windows at 
home and in the car, although behavioural aspects were 
in line with other resistors. Overall the ‘integrated’ group 
had a moderate score, although half had a low score 
indicating that their routines were often not sufficiently 
rigorous (table 1).
DIsCussIon
Three broad groups of responses to photoprotection were 
identified. One group, termed ‘integrated’ represent what 
is often regarded as the ideal form of adjustment among 
people with a chronic condition and represents the final 
stage of the self-management pathway in chronic illness that 
is often referred to as ‘normalisation’. This term sometimes 
emphasises psychological aspects in terms of bracketing 
off the impact of illness so that its effects on the person’s 
identity are relatively slight,23 or may refer to the incorpo-
rating of illness or treatment regimens into what is viewed 
as a normal life.24 Patients categorised as ‘integrated’ 
displayed both features of normalisation; they no longer 
felt concerned about possible negative responses and their 
photoprotection had moved from a deliberative to an auto-
matic and habitual process and was now a routine part of 
their life. This successful adaptation was accompanied by 
photoprotection practices they felt comfortable and confi-
dent with, although participants’ accounts and adherence 
scores indicated that they did not necessarily achieve the 
ideal in terms of rigorous photoprotection and had a more 
moderate level of photoprotection. In contrast those ‘domi-
nated’ by the requirements of photoprotection achieved 
high levels of UVR protection but at a high cost in terms of 
activity restrictions and emotional distress and resulted in, 
what Sanderson et al in their study of rheumatoid arthritis 
referred to as, a ‘disrupted normality’.25 However, for XP 
this disruption largely occurred through the visibility and 
demands of protective measures rather than through over-
whelming pain or other physical symptoms. A third group 
of ‘resistors’ did not aim to normalise photoprotection, with 
the ‘strong resistors’ engaging in, what Sanderson et al25 
referred to as, ‘struggling for normality’ at all costs, possibly 
trading short-term social normality for increased clinical 
risks and reduced normality in the longer term. This reflects 
descriptions of ‘denial’ of an illness identity and responses to 
stigma in relation to a range of chronic conditions, particu-
larly among adolescents and young adults.26–28 In contrast, a 
few ‘occasional resistors’ partly normalised photoprotection 
in their life and described some established photoprotection 
routines but also questioned the personal priority of photo-
protection and acknowledged sometimes going outside for 
short periods without bothering to apply sunscreen.
This study thus identifies some similarity in the responses 
of people with XP and those identified for other chronic 
diseases. It is also notable that the group ‘dominated’ by 
photoprotection and who had the highest adherence scores 
experienced considerable psychosocial disruption, whereas 
those who had achieved greater psychosocial normalisation 
disclosed that they did not necessarily do all they could in 
terms of photoprotection and had lower photoprotection 
scores. It was also clear that some apparently irrational 
behaviour, particularly among the ‘resistant’ group, was 
perceived as rational by these participants given the impor-
tance they assigned to having a normal life and identity. 
The differing behavioural responses to XP correspond with 
Horne et al’s ‘Necessity-Concerns’ framework29 developed to 
explain medicines use, with individuals’ photoprotection 
Table 1 Clinical assessment of photoprotection protection 
score * for three behavioural categories
Behavioural
categories Range†
Mean 
protection 
score (SD)
Protection 
score rating*
‘Dominated’ 16–20 18.25 (2.06) High
‘Resistant’ 3–14 6.18 (3.25) Low
‘Integrating’ 7–15 9.90 (3.00) Moderate
High score=15–20, moderate score=9–14, low score=0–8.
The score does not take account of ultraviolet radiation 
protection with heavy curtains or blinds, with only dermagard 
window film at home receiving a score (100% day protected=6; 
50% day=3). This reduced the score for people who spent 
most of their time indoors with curtains or blinds pulled.
*Based on Ultraviolet Radiation Protection Measure applied by 
specialist nurses (Henshaw and Turner, 2016).21
†Scores out of 20 based on 13 items covering five areas: (1) 
Window film. (2) Sunscreen. (3) Face visor or glasses/ultraviolet 
radiation eye protection/face buff/hat. (4) Hand protection. (5) 
Arms/legs covered.
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practices reflecting their perceptions and balancing of the 
perceived necessity of photoprotection to reduce UVR risks 
with concerns about the impacts of photoprotection on activ-
ities, feelings of stigma and emotional distress. For the group 
‘dominated’ by photoprotection their belief in the neces-
sity of photoprotection clearly outweighed the emotional 
distress and activity restrictions they experienced, whereas 
these psychosocial concerns were of particular significance 
and influences on the behaviours of the group of ‘strong 
resistors’. This  may have been influenced by their age and 
life stage, personality and general orientation to risk taking, 
although these aspects were not investigated. More broadly, 
the data indicate that changes in either perceived necessity 
of photoprotection or concerns about the impacts of photo-
protection could lead to shifts in behaviour.
The study interviews focused on individuals’ current 
perceptions and behaviours in terms of accommodating and 
coping with requirements for photoprotection. However, a 
few participants described transitions. One transition was 
from ‘resisting’ to ‘dominated’ that was triggered by greater 
perceived necessity through their experience of a skin cancer. 
There was also evidence of a shift towards ‘integration’ 
which appeared to be influenced by increasing age, greater 
resilience and changing social expectations. However trig-
gers and processes of change between different behavioural 
responses require detailed study with a longitudinal design. 
There are also questions of the influence of early childhood 
experiences, including feelings of stigma and the emphasis 
given by families to either facilitating their child’s partici-
pation in normal activities or engaging in a UVR avoidant 
strategy involving restricted time outside.30 31 These early 
experiences may thus have shaped adults lifestyle choices 
and their attitude to health risk which is known to have an 
important influence on preventive health risk behaviour 
and treatment preferences.32 Researching these issues 
would contribute to what Moss-Morris33 noted is a need for 
a more adequate understanding and theory of adaptation 
to chronic illness, while Leventhal et al34 recommended that 
greater attention should be given to the dynamic processes 
involved in coping with chronic illness and key transitions, 
including transitions in relation to adherence.
study limitations
The study of a rare disease involves a number of challenges.35 
These include the necessarily limited study population that 
requires particular attention to ensuring confidentiality and 
anonymity and risks of considerable respondent burden. For 
example, it was not feasible to undertake further follow-up 
interviews to explore emerging issues in greater depth or 
undertake respondent validation as this patient sample 
was also participating in other phase I studies and will be 
invited to participate in the subsequent trial. A further 
limitation is that clinic attenders with neurodegeneration, 
which occurs in around a quarter of people with XP,9 were 
excluded as they are likely to face considerably different 
issues to people without neurodegeneration and thus 
require a separate study.
Informing behavioural interventions
This qualitative study complements the quantitative aspects 
of the phase I programme and provides greater depth and 
richness of data to explain the ‘why’, ‘what’ and ‘how’ ques-
tions. For example, why participants went out in the sun 
without full protection, what they felt were the impacts of 
photoprotection on their lives, whether and what they 
disclosed to friends, and how they responded to questions 
about their appearance.
These findings will inform the design of the interven-
tion in a number of ways. This includes identifying people 
‘dominated’ by photoprotection who already have a very high 
level of adherence and for whom the intervention would 
therefore not be appropriate. However, their accounts 
of emotional distress identified the potential risks asso-
ciated with high levels of photoprotection and indicates 
that emotional well-being will need to be probed in the 
intervention sessions and responded to for individuals as 
appropriate.
The study identified people ‘who were resistant’ to photo-
protection as having few established routines and most likely 
to experience a constellation of barriers to photoprotection, 
while those categorised as ‘integrated’ shared some of these 
barriers. This indicates that the intervention should include 
both generic components and components personalised to 
the specific barriers relevant to each person with the aim of 
changing individuals’ necessity-concerns balance. Generic 
components might include developing positive ‘habits’ that 
refer to a situation in which a stimulus (eg, going outside) 
generates an impulse to act as a result of a learnt stimulus 
response, with a positive cue-action link leading to protec-
tive behaviours.36 Habit formation training could involve 
action planning and the use of environmental cues and 
prompts (eg, intervention text message) to instigate the 
specific photoprotection behaviour. The components to 
address specific needs and barriers could include strategies 
to enhance acceptance and willingness to photoprotect as 
well as strategies to reduce felt stigma by managing appear-
ance concerns and to facilitate disclosure. Patients’ accounts 
of their lived experiences provided by the qualitative inter-
views could also be included in written materials to support 
the one-to-one sessions and overcome personal barriers to 
photoprotection through drawing on the direct experience 
of other patients.
ConClusIons
This study goes beyond the identification of themes to 
examine the complexity and patterning of responses, 
including the influence of patients’ illness experience, prior-
ities and circumstances of their lifeworld37 on their photo-
protection behaviour, and contributes to an understanding 
of adaptation and normalisation in chronic illness. The data 
will also inform the content and design of individualised 
interventions to address both motivational and volitional 
barriers to photoprotection of people with XP and may also 
be of value for other conditions with high risks of skin cancer.
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